drugset / Trial / NCT03614975

Immunologic Response to Influenza Vaccination in Children and Adolescents

NCT03614975

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate immunologic response to different types of influenza vaccine among children/adolescents/young adults 4-20 years of age. This is a randomized controlled trial (RCT), that will assess immune response in 120 participants (60 per vaccine arm) pre- and post-vaccination to Flucelvax (egg-free inactivated flu shot) and Fluzone (egg-based inactivated flu shot).

Timeline

Start
2018-09-13
Primary completion
2018-12-13
Completion
2018-12-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Flucelvax Vaccine 0.5 ml Intramuscular
Comparator Influenza Virus Vaccine Vaccine 0.5 ml Intramuscular

Indications